Concepedia

Mark R. Fleisher

MR

Statistics

Publications

12

Citations

1.6K

H-Index

11

Active since

1989

Affiliations

Borland Groover Clinic(Current)

Mayo Clinic in Arizona

Lenox Hill Hospital

Indiana University – Purdue University Indianapolis

Mark R. Fleisher is an author at Borland Groover Clinic specializing in medicine, inflammatory bowel disease, and inflammation.

Publications per year

1989–2021

12

Publications

12

A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease

William J. Sandborn, Brian G. Feagan, Richard N. Fedorak et al. · Gastroenterology · 2008 · 746 citations · Full text

Veterinary Medicine, Clinical Sciences, Immunology +16

Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease

Miguel Regueiro, John F. Valentine, Scott E. Plevy et al. · The American Journal of Gastroenterology · 2003 · 224 citations

Medicine, Immunology, Pharmacotherapy +17

Malignant Neoplasms Subsequent to Treatment of Inflammatory Bowel Disease With 6-Mercaptopurine

Burton I. Korelitz, Felice Mirsky, Mark R. Fleisher et al. · The American Journal of Gastroenterology · 1999 · 136 citations

Medicine, Oncology, Chemotherapy +9

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · The Lancet. Gastroenterology & hepatology · 2021 · 93 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Cerebrospinal fluid ß <sub>2</sub> microglobulin in patients infected with human immunodeficiency virus

Bruce J. Brew, Rhythm Bhalla, Mark R. Fleisher et al. · Neurology · 1989 · 83 citations

Life Sciences, Neurology, Neuroscience +11

1–5 of 12